Dea No. 7369

Dea No. 7369 Brand names, Dea No. 7369 Analogs

Dea No. 7369 Brand Names Mixture

No information avaliable

Dea No. 7369 Chemical_Formula

C₂₁H₃₀O₂

Dea No. 7369 RX_link

http://www.rxlist.com/cgi/generic2/drona.htm

Dea No. 7369 fda sheet

Dea_No._7369 FDA

Dea No. 7369 msds (material safety sheet)

Dea_No._7369 MSDS

Dea No. 7369 Synthesis Reference

No information avaliable

Dea No. 7369 Molecular Weight

314.462 g/mol

Dea No. 7369 Melting Point

200 ^oC at 2.00E-02 mm Hg

Dea No. 7369 H₂O Solubility

2.8 mg/ml

Dea No. 7369 State

Solid

Dea No. 7369 LogP

5.648

Dea No. 7369 Dosage Forms

Capsule

Dea No. 7369 Indication

For the treatment of anorexia associated with weight loss in patients with AIDS, and nausea and vomiting associated with cancer chemotherapy in patients who have failed to respond adequately to conventional antiemetic treatments

Dea No. 7369 Pharmacology

Dronabinol may has complex effects on the central nervous system (CNS), including cannabinoid receptors. Dronabinol may inhibit endorphins in the emetic center, suppress prostaglandin synthesis, and/or inhibit medullary activity through an unspecified cortical action.

Dea No. 7369 Absorption

90 - 95%

Dea No. 7369 side effects and Toxicity